Drugs / SAR247799
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03462017 | Mar → Dec 2018 | coronary microvascular disorder | Sanofi | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SAR247799 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03462017 ↗ |
| Action | Activate | “designed to activate endothelial S1P1” PMID 33125753 ↗ Nov 2020 |
| Route | Oral | “Route of administration: Oral” NCT03462017 ↗ |